编辑政策

宗旨及范围

Remit of the Journal

The editorial policy of the journal is based on traditional ethical principles of scientific periodicals, developed by the Committee on Publication Ethics (COPE) for editors, reviewers and authors. The editorial board of the journal is governed by the principles of scientific, objectivity, professionalism and impartiality.

 Priority topics for the original articles:

• reconstructive surgeries on major joints
• primary and revision arthroplasty of major joints
• complex cases of arthroplasty
• data of registers for various fields of traumatology and orthopedics
• manufacturing and application of customized implants with the use of 3D technology
• diagnostics and treatment or periimplant infection
• new technologies in arthroscopy

The journal also publishes analytical and systematic reviews of literature, as well as meta-analyses on current topics, being of interest to a wide range of readers and based on a critical analysis of modern literature sources. We publish lectures and rare clinical cases with discussions in order to improve the skills of practitioners. The most interesting articles are commented by leading experts in the corresponding field. We accept short articles for anniversaries and memorials, as well as information and reports on research and practice conferences and symposia.

栏目要求

Editorials

Registry data

Clinical studies

Reviews

Lectures

Discussions

Case Reports

Comments

Letters to Editor

News

History of medicine

Anniversaries

Obituaries

Figures and facts

Vreden's Readigs

同⾏评审过程

All submitted manuscripts undergo a peer review before publication. The peer review process can be broadly summarized into 4 stages.

The first stage – editorial office assessment. The handling editor checks the paper’s composition and arrangement against the journal’s Author Guidelines to make sure it includes the required sections and stylizations. The handling editor checks also that the paper is appropriate for the journal and is sufficiently original. Each article is evaluated for possible plagiarism by Antiplagiat system for Russian-language papers and by Duplichecker – for English-language papers. If the paper is not appropriate it may be rejected without further peer review. As a rule, this stage takes about 5-7 days.

The second stage – the statistical review: the assessment of statistical methods correctness by an expert in biomedical statistics. Duration – about 7 days.

The third stage – double-blind peer review in which both authors and reviewers are unknown to each other. The handling editor sends invitations to individuals he or she believes would be relevant in that field. The decision on the reviewer selection is made by the editor-in-chief, deputy editor-in-chief or executive secretary of editorial board. If necessary, additional invitations are sent to experts until at least two consents for reviewing are received. This stage takes about 4 weeks, but it can be extended on the reviewer request.

Each review is submitted to the journal, with one of the following recommendation:

• accept paper;
• revisions required;
• resubmit review;
• reject paper.

If the reviews differ widely, the editor may invite an additional reviewer so as to get an extra opinion before making a decision.

All reviewer’s comments are sent by email to the author(s). Authors also can track the review stages in their personal account on the journal's website.

Authors can revise a paper within 3 months. The revised paper is re-submitted for peer review. In total, there are two rounds of peer review, i.e. authors can correct the paper in accordance with the reviewer’s comments two times. If only minor changes were requested this follow-up review might be done by the handling editor. If the authors refuse to edit the article, they must inform the editorial board about it.

The fourth stage. Upon receipt of the revised submission, the manuscript undergoes final stage of the review process. Positive reviews does not guarantee the acceptance, as final decision in all cases lies with the Editorial Board. By his authority, editor-in-chief rules final solution of every conflict.

The editorial board permits not more than 3 cycles of reviewing.

Upon the decision to accept the manuscript for publishing, the editorial staff notifies the authors of the scheduled date of publication.

Original reviews of submitted manuscripts remain deposited for 5 years.

All reviews are uploaded in the RSCI and added to the reviewer's personal account.

出版周期

Regular issues publish quarterly, 4 times a year.

开放式获取政策

“Traumatology and Orthopedics of Russia” is an open access journal. All articles are made freely available to readers immediatly upon publication.

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition - it means that articles have free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself.

For more information please read BOAI statement.

This journal's articles are licensed under Creative Commons Attribution 4.0 International (CC BY 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

 

存档

The journal uses the PKP Preservation Network (PKP PN) to digitally preserve all the published articles. The PKP PN is a part of LOCKSS (Lots of Copies Keep Stuff Safe) program offers decentralized and distributed preservation, seamless perpetual access, and preservation of the authentic original version of the content.

The journal makes archives in Portico for compliance with the MEDLINE preservation requirement for electronic journals. Portico is a community-supported preservation archive that safeguards access to e-journals, e-books, and digital collections.

Also, the journal makes full-text archives on the Russian Science Electronic Library (eLibrary.ru) platform.

作者自存档

The journal is compliant with Platinum Open Access mode for articles distribution that includes Open Self-Archiving policy.

Editor rejection

Reasons for rejection of manuscripts by the editor without transfer to reviewers:

 

• the design of the manuscript does not meet the requirements of the journal;
• the manuscript does not meet the criteria of any of the journal section;
• the volume of the manuscript significantly exceeds the maximum allowable one;
• the materials of the manuscript do not contain illustrative material, statistical analysis of the results obtained, or are presented in an exceptionally concise form, which does not allow assessing the quality of the presented material.
• Correspondence author ORCID profile does not content publicly available information.

Publishing Ethics

Extract from the Code of Ethics of Eco-Vector Publishing house (full text)

Publisher and Editorial

 Independently and impartially make decisions about publication:

• Reject;
• Resubmit;
• Accept;
• Retract.

Responsibility and rights of authors

 When submitting a manuscript to a journal, authors should ensure that:

• all participants who have made a significant contribution to the study are presented as Co-Authors;
• those who did not participate in the study are not listed as Co-Authors;
• all Co-authors saw and approved the final version of the work and agreed to submit it for publication (this is confirmed by the signatures of all authors in the cover letter).

The author should not

1. hide any conflicts of interest that may affect the result and interpretation of the work (*);
2. publish the submitted manuscript in other publications and hide from the Editorial Office the transfer of the manuscript to another publication (**);
3. deviate or ignore the Journal's instructions for preparing and sending manuscripts, instructions for working with proofreading instructions regarding deadlines and other instructions of the Editorial Board;
4. evaluate the work of reviewers.

Violation of the prohibitions will be regarded by the editors as unethical behavior. The manuscript may be rejected by the Editors

In case of violation of paragraph 3, the Publishing House informs the Editor-in-Chief about the unethical behavior of the authors.

The authors adhere to:

• publication ethics;
• instructions for submitting a manuscript to the journal;
• the instructions contained in the letters received and the deadlines indicated in them;
• instructions for working with proofreading.

The authors have the right to:

• withdraw the article at any stage of its consideration
• report the discovery of significant errors in a published article

Responsibility and rights of Reviewers

The reviewer should not

• participate in the review of manuscripts in case of conflicts of interest due to competitive, joint and other interactions and relationships with any of the Authors, companies or other organizations associated with the submitted work;
• use unpublished data obtained from submitted manuscripts in personal research without the written consent of the Author;
• discuss the manuscript with anyone not authorized to do so by the Editor.

Reviewers should

• inform the Editor about the discovery of a significant similarity or coincidence between the manuscript in question and any other published work that is within the scientific competence of the Reviewer;
• keep confidential and not use information or ideas obtained during the review for personal gain.
• avoid personal criticism of the Author and try to give an objective assessment of the manuscript.

Bioethics

If animals or people were involved in the work as objects of research, the manuscript should indicate that all stages of the study comply with the legislation and regulatory documents of research organizations, and are also approved by the relevant ethical committees.

The authors are obliged to follow ethical principles of conducting medical research involving people, animals, and vulnerable populations.

Patients and respondents participating in a study should be fully informed about the purpose of the study, its results, and the consequences of participating in the study.

 Vulnerable populations include

• women of reproductive age, minors, elderly and senile patients, people with mental, cognitive and sensory disorders,
• patients in an emergency, terminally ill or unable to give informed consent,
• small ethnic groups

 The editors have the right to request

a copy of the opinion of the ethical committee, informed consents, copies of questionnaires, etc.

The editors refer the following to violations of publication ethics:

• illegal borrowing of text, figures, tables;
• simultaneous submission of a manuscript to several journals;
• concealment of a conflict of interest;
• assessment of the professional qualities of reviewers;
• illegal co-authorship;
• multiple publications.

(*) Examples of potential conflicts of interest to be disclosed:

• receiving financial rewards for participating in a study or writing a manuscript;
• any connection (contract work, consulting, shareholding, receiving fees, providing expert opinions) with organizations that have a direct interest in the subject of the study or review;
• patent application or patent registration for research results (copyright, etc.);
• obtaining financial support for any stage of the research or writing of the manuscript (including grants and other financial support).
• Information about conflicts of interest received from the authors of the manuscripts should be available only to the editorial board when deciding whether to publish the manuscript. Then information about conflicts of interest should be published as part of the full text of the article.
• The publisher recommends using the interactive form at https://admin1.journals.elsevier.com/media/bpwkqcoc/coi_disclosure.pdf when writing this part of the manuscript.

(**) The publication of a certain type of article (for example, translated articles) is permitted in some cases, subject to a number of conditions. When submitting a manuscript for secondary publication, the authors must notify the editorial board about this and justify in detail the feasibility of such publication. In the case of a secondary publication, the settlement of issues related to copyright for publication is decided individually in each specific case. The general rules for preparing a manuscript for a "secondary" publication are: indicating a full bibliographic reference to the primary publication, preserving the original bibliography of the primary work.

Attribution of authorship

Editorial board emphasize that:

Only those persons who have made a significant contribution to the conception of the work, the development, execution, and/or interpretation of the results of the presented study, as well as to the process of writing the manuscript (including scientific and stylistic editing and design in accordance with the requirements of the journal) may be recognized as the Authors of the publication.

When submitting a manuscript to the journal, Authors shall ensure that:

• All participants who made a significant contribution to the reported study are presented as Co-Authors;
• Those who did not participate in the study are not listed as Co-Authors;
• All Co-Authors have read and approved the final version of the paper and agreed to its submission for publication—this shall be confirmed by the signatures of all Authors in the cover letter.

Identification of illegal borrowings is carried out:

• as part of scientific peer review;
• through the ANTI-PLAGIARISM system.

At this stage of expertise:

• The editors do not take into account the percentage of originality calculated by the anti-plagiarism program;
• The editors relies only on an expert analysis of the full report of the program;
• The editors allow for complete coincidence in the description of the applied research methods with such in previously published articles, textbooks, manuals.;
• The editors believe that the introduction, results, discussion and conclusion (conclusions) should be completely original.

If conclusions coincide with those formulated earlier by other researchers, this should be explicitly indicated in the manuscript in the discussion section.

Disclosure of Potential Conflicts of Interest

All Authors must disclose in their manuscript ― declare in the appropriate section of the manuscript ― any financial or other relevant interests that might be construed to influence the findings or interpretation of their research.

Examples of potential conflicts of interest to be disclosed are given below:

• Receiving financial rewards for participating in the research or writing of a manuscript;
• Any affiliation (contract work, consulting, equity assets, fees, and expert opinions) with organizations that have a direct interest in the subject matter of the research or review;
• A patent application or registration for research findings (copyright, etc.);
• Receiving financial support for any of the stages of conducting the research or writing a manuscript (including grants and other forms of financial support).

Information on conflicts of interest received from the Authors of manuscripts should be available only to the Editorial Board when deciding whether to publish the manuscript. Such information on conflicts of interest shall then be published as part of the full text of the paper.

When writing this part of the manuscript, the Publisher recommends using the interactive form available at https://admin1.journals.elsevier.com/media/bpwkqcoc/coi_disclosure.pdf

A Reviewer shall not participate in the review of manuscripts if there are conflicts of interest due to competitive, collaborative, and other interactions and relationships with any of the Authors, companies, or other organizations related to the submitted paper.

Editors recuse themselves from reviewing manuscripts if there are conflicts of interest due to competitive, collaborative, and other interactions and relationships with Authors, companies, and possibly other organizations related to the manuscript.

Confidentiality and personal data

The Editor and the Editorial Board shall not unnecessarily disclose information on the manuscript under consideration to anyone other than the Authors, Reviewers, possible Reviewers, other Academic Advisors, and the Publisher.

The Editor shall not use unpublished materials disclosed in the submitted manuscript in the Editor’s own research without the written consent of the Author.

Reviewers shall not use unpublished materials from the submitted manuscripts in the Reviewer’s own research without the written consent of the Author.

Reviewers must keep information or ideas obtained during the review process confidential and not use them for personal gain.

Reviewers shall not discuss the manuscript with any person not authorized by the Editor.

Identifiable (personal) information, including patient names and initials or hospital numbers, shall not be published in written descriptions, photographs, and genetic pedigrees unless the information is of great scientific or historical value and the patient (or parent or guardian) gives written consent for its publication.

Ethical guidelines for handling personal data in biomedical research involving human subjects must comply with legal acts, such as the Council for International Organizations of Medical Sciences (CIOMS) International Ethical Guidelines for Health-Related Research Involving Humans (2016)―in particular, Guideline No. 12 “Collection, Storage and Use of Data in Health-Related Research”  ― as well as the Russian Federal Law on Personal Data (No. 152-FZ), implemented on July 27, 2006 .

Data sharing policy

Authors are encouraged to make the research data that support their publications available but are not required to do so. The decision to publish will not be affected by whether or not authors share their research data.

Definition of research data

This policy applies to the research data that would be required to verify the results of research reported in articles published in the journal “Traumatology and Orthopedics of Russia”. Research data include data produced by the authors (“primary data”) and data from other sources that are analysed by authors in their study (“secondary data”). Research data includes any recorded factual material that are used to produce the results in digital and non-digital form. This includes tabular data, code, images, audio, documents, video, maps, raw and/or processed data.

Definition of exceptions

The data that is not a subject to public disclosure may be delivered as follows: deposited in science data repositories with limited access or preliminary anonymised. An author can also publicly deliver metadata only and/or description of the method of access to the data under requests from other scholars.

Data repositories

The preferred mechanism for sharing research data is via data repositories. Please see or https://repositoryfinder.datacite.org/ for help finding research data repositories.

Data citation

The Editorial Board of the Journal “Traumatology and Orthopedics of Russia”welcomes access to data under Creative Commons Licenses. Editorial Board of the Journal “Traumatology and Orthopedics of Russia”does not insist on the obligatory use of Creative Commons in case when the data is deposited in the repositories of the third party. The Publisher of the Journal “Traumatology and Orthopedics of Russia” does not assert any copyrights for the data submitted by the author together with the article.  

Questions regarding the observation of that policy shall be sent to the executive secretary of the Journal “Traumatology and Orthopedics of Russia”.

Adverticement and reprint policy

Our advertising policy is consistent with the principles mentioned in the Recommendations on Publication Ethics Policies for Medical Journals which issued by the World Association of Medical Editors (WAME).

http://www.wame.org/recommendations-on-publication-ethics-policie

1. The journal generates revenue for the Publisher (Eco-Vector) from advertising, which creates a potential conflict of interest with the Editorial Team. Editors’ decisions do not depend on the cost of advertising or producing reprints. Advertisers and sponsors have no influence over the editor’s decisions, regardless of the terms of advertising or other agreements.
2. All advertisements are subject to the approval of the Eco-Vector’s staff, which reserves the right to reject or cancel any advertisement at any time.
3. The functions of editors and advertising managers in Eco-Vector’s journals are separate.
4. In Eco-Vector’s journals professional (physician-directed) publications and web sites, the intentional placement of advertising adjacent to articles discussing the company or product that is the subject of the advertisement is prohibited. Advertising content must be distinguished from editorial and other materials so that the difference between them is obvious.
5. Eco-Vector will not publish “advertorial” content, and sponsored supplements must be clearly indicated as such. If a supplement did not undergo peer review or underwent a peer review-process different from the rest of the journal that should be explicitly stated.
6. All Eco-Vector’s journals have the right to refuse any advertisement that, in its sole discretion, is incompatible with its mission or inconsistent with the values of members, the publication/web site or the organization as a whole, and to stop accepting any advertisement previously accepted. Advertisements are subject to review by the editors and others at the Eco-Vector’s journals. In no case shall separate agreements with Eco-Vector’s journals or its subsidiaries supersede this policy.
7. Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Eco-Vector’s staff request its removal.
8. Advertising for the following categories is prohibited:
   
   • Alcohol
   • Tobacco
   • Weapons, firearms, ammunition
   • Fireworks
   • Gambling and lottery
   • Pornography or related themes
   • Political and religious advertisements
   • Advertisements that claim to have a “miracle” cure or method
   • Advertisements that make unsubstantiated health claims for the products advertised
   • Advertisements directed at children
9. Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
10. All advertisements are accepted and published by Eco-Vector on the warranty of the advertisement agency and advertiser that both are authorized to publish the entire contents and subject matter of the advertisement.
11. In consideration of publication of an advertisement, the advertiser and the advertisement agency, jointly and severally, agree to indemnify and hold harmless Eco-Vector, its officers, agents and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement, including, without limitation, claims or suits for libel, violation of privacy, copyright infringement, or plagiarism.
12. Any references to Eco-Vector or its products or services in advertisements, promotional material, or merchandising by the advertiser or agency is subject to Eco-Vector’s written approval for such use.
13. All advertisements for drug-specific campaigns must comply with the relevant Russian legislation that regulates advertising. Advertisers should make available to Eco-Vector the marketing authorization and summary of product characteristics when submitting their advertisement. In the case of drug advertisements, proprietary names of pharmaceutical products must be accompanied by the chemical, generic, or official name; the quantity of all active substances must be stated along with the recommended dosage. Each page of an advertisement for a prescription-only medicine should be clearly labeled as intended for health professionals.
14. Advertisements for products not approved by the FDA or the Ministry of Health of Russian Federation that make any kind of health claims must carry the following disclaimer: “These statements have not been evaluated by the Food and Drug Administration and/or the Ministry of Health of Russian Federation. This product is not intended to diagnose, treat, cure or prevent any disease.”
15. While Eco-Vector’s journals welcomes and encourages information-rich advertising, advertisements, advertising icons and advertiser logos must be clearly distinguishable from editorial content and may require special labeling to distinguish them as such. All advertisements must clearly and prominently identify the advertiser by trademark or signature.
16. Reprints should be published only in the form in which they were originally published in the journal (including subsequent corrections), so there should be no additions or changes in them.
17. Publisher is not responsible for incidental or consequential damage for errors in displaying or printing an advertisement.
18. Advertisements may not imply endorsement by the Eco-Vector’s journals or its publications/web sites except as may be provided for under a separate agreement — in which case advertising must be pre-approved to ensure adherence to the letter and spirit of that separate agreement.
19. The full rules for any market research or promotion associated with an advertisement must be displayed in the advertisement or available via a prominent link.
20. The following online advertising formats are prohibited:
    
    • Pop-ups and floating advertisements.
    • Advertisements that collect personally identifiable information from visitors without their knowledge or permission.
    • Advertisements that extend across or down the page without the visitor having clicked or rolled-over the advertisement.
    • Advertisements that send visitors to another site without the visitor having clicked the advertisement.

Eco-Vector’s journals published advertising policies are not exhaustive and are subject to change at any time without notice.

We partner with third-party advertising companies to serve ads and/or collect certain information when you visit our website. These companies may use cookies or web beacons to collect non-personally identifiable information [not including your name, address, email address or telephone number] during your visit to this website to help show advertisements on other websites also likely to be of interest to you.

For contact with the Advertisement department of the Publisher, please, follow the link https://eco-vector.com/

Retraction

Retraction’s reasons

The retraction of an already published article is an extreme measure and is applied in the event of the disclosure of facts that were not known during the review.

Reasons for retraction are as follows:

• detection of incorrect borrowings (plagiarism) in the publication;
• duplication of the article in several publications;
• detection of falsifications or fabrications in the work (for example, manipulation of experimental data);
• detection of serious errors in the work (for example, misinterpretation of the results), which calls into question its scientific value;
• detection of persons who do not meet the criteria for authorship;
• a conflict of interest was not announced;
• article was republished without the consent of the author;
• the article has not been peer reviewed.

Retraction procedure:

• Authors, readers, reviewers, editors, and the Publisher can initiate a retraction of a paper by application to the editorial office of the Journal.
• The Retraction Commission reviews the received application and notifies the interested parties about the beginning of the retraction procedure.
• The Retraction Commission decides to retract the published paper if there are sufficient facts in favor of retraction.
• The Retraction Commission notifies the initiator of the retraction of the paper about the results of consideration in written form.
• If the commission decides to retract the paper, the Journal publishes information that the paper has been retracted, including the metadata of the retracted paper.
• If papers from the Journal are indexed by any databases, a letter is sent to these databases stating that this paper has been retracted, indicating the reasons for retraction.
• The editorial board has the right to independently decide on additional sanctions – for example, on the inclusion of authors in the blacklist of the Journal for a certain period, or indefinitely.

Appeal

Issues upload

Published articles are exported to the Scientific electronic library (eLibrary.ru) within three weeks after publication of all language versions at the official journal site.

Authors fees

Marketing

Readers and authors of the journal can connect to the RSS feed to receive up-to-date information about the journal.

As part of scientific and practical events (conferences, symposiums), participants are provided with a free copy of the journal.

The publisher does not send requests to potential authors to submit manuscripts.

The publisher provides an opportunity for reviewers to submit a review to Publons.

Postpublishing changes

As part of the policy of post-publishing changes, the following types of articles are published in the journal.

Clarification

A variety of Erratum. The article does not report errors but clarifies the data of a previously published article.

Comment

Work consisting of a critical or explanatory note written to discuss, support, or dispute an article or other presentation previously published. It may take the form of an article, letter, editorial, etc. It appears in publications under a variety of names: comment, commentary, editorial comment, viewpoint, etc.

Correspondence

Letter to the editor or a reply to the letter.

Correction

An article describing the corrections made in an article previously published in the same journal. This type of publication is not a variant of Erratum.

Corrigendum

Article in which errors are reported that were made by authors in an earlier publication in the same journal.

Duplicate

Accidental duplication of an article in another Eco-Vector's journal. The text of the article is retracted. The HTML pages are replaced by a single page with citation details and an explanation. The PDF pages remain with a watermark on every page to notify it is a duplicate.

Editorial

Work consisting of a statement of the opinions, beliefs, and policy of the editor or publisher of a journal, usually on current matters of medical or scientific significance t

Erratum

Article in which errors are reported that were made in an earlier publication in the same journal. Can be Erratum (publishing error) but also Corrigendum (author error).

Expression of Concern

A notification about the integrity of a published article that is typically written by an editor and should be labelled prominently in the item title. It is the responsibility of the editor to initiate appropriate investigative procedures, discover the outcome of the investigation, and notify readers of that outcome in a subsequent published item. The outcome may require the publication of a retraction notice.

Removal

Editorial notice of the removal of a previously published article.

The text of the article is removed. The HTML pages and PDF pages of the article are completely removed and replaced by a single page with citation details and an explanation.

Retracted publication

The text of the article is retracted. The HTML pages are replaced by a single page with citation details and an explanation. The PDF pages remain with a watermark on every page to notify it is retracted.

Retraction of Publication

Editorial notice of the retraction of a previously published article.

Withdrawal

Refutation of an article previously published in the same journal (in a situation where retraction cannot be performed).

For details see Crossmark Policy.

Indexation

Articles in “Traumatology and Orthopedics” are indexed by several systems:

• Russian Scientific Citation Index (RSCI)
• SCOPUS
• EMERGING SOURCES CITATION INDEX (Web of Science™ Core Collection)
• Google Scholar
• Base.
• CyberLeninka
• Dimensions
• DOAJ (Directory of Open Access Journals) 
• NLM Catalog

Manuscript submission

If you have read the editorial policy and found that the results of your research correspond to the subject of the journal, you may get to the manuscript submission page.

Manuscript withdrawal

Authors can withdraw their manuscript at any stage of consideration and preparation for publication (including in electronic form on the website in Online First mode).

Withdrawal procedure

The author's team sends a letter to the official address of the editorial office with a request to withdraw the manuscript from consideration or publication, indicating the reason. The letter must contain a scanned appeal of the author's team with the signatures of all co-authors (PDF).

The editorial board notifies the authors of the receipt of the letter.

Within a week, the Editorial Board notifies the authors of the withdrawal of the manuscript from consideration or the termination of its preparation for publication and moves the manuscript to the electronic archive by means of the editorial and publishing platform.

If the authors have not received a response from the editorial board within a week, then you should contact the publisher or the editor-in-chief of the journal, attaching the correspondence.

If, despite sending messages to the editorial office, the publisher and the editor-in-chief, the article being withdrawn was published in the journal (including it was published electronically on the website in Online First mode), the withdrawal of the manuscript is possible only through the retraction procedure (see Retraction)

---